Treatment
0.01% Atropine clinical trials
We’re tracking 8 recruiting studies that include 0.01% Atropine, each written for real people, not researchers, below.
Recruiting studies
- NCT06708156RecruitingPhase 3
Low-dose atropine drops to slow childhood nearsightedness
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
Hefei, AnhuiAges 6–12 - NCT07537166Enrolling by invitation
Atropine Drops and Ear Acupressure for Childhood Myopia
This trial tests whether very low-dose atropine eye drops combined with acupressure on the ear can slow down myopia (nearsightedness) progression in children. Researchers will also check how the treatment affects the inner eye tissue.
Taichung, North StrictAges 6–12 - NCT07456488RecruitingPhase 2
Atropine eye drops for nearsighted children
This study tests if low-dose atropine eye drops can slow down worsening nearsightedness in children. Children in the study receive either the drops or no treatment, and their vision changes are tracked over time.
Karachi, SindhAges 4–16 - NCT07176949Recruiting
Early myopia prevention study for young children
This study tests a program to prevent or slow down early nearsightedness (myopia) in children ages 3 to 6. It aims to find out if certain eye care methods can help keep their vision healthy.
Shanghai, Shanghai MunicipalityAges 3–6 - NCT06034379Recruiting
Special glasses vs. eye drops for nearsighted kids
This study compares two ways to slow down worsening nearsightedness in children: special electronic glasses versus low-dose atropine eye drops. It may help your child keep their eyesight from getting much worse over time.
HsinchuAges 6–13 - NCT05379855Recruiting
Eye drops for eye alignment and double-vision control in children
This study tests eye drops to improve how a child’s eyes line up and how well they can use both eyes together. It may help children with certain types of outward eye drifting (intermittent exotropia/exophoria).
ShanghaiAges 5–14 - NCT04252989Recruiting
Atropine eye drops for slowing worsening nearsightedness in kids
This trial studies using low-dose atropine eye drops to help slow worsening nearsightedness (myopia) in children. It may help kids whose myopia is actively getting worse, depending on how consistently the drops are used.
Saint-EtienneAges Up to 18 years - NCT06389110RecruitingPhase 3
Low-dose atropine drops to slow children's nearsightedness
This study tests whether a very low-dose atropine eye drop (0.01%) can safely slow down worsening nearsightedness in children. It is for kids ages 3 to 12 who are already nearsighted but haven't used other myopia control treatments before.
Mexico CityAges 3–12
What 0.01% Atropine is being studied for
Conditions with recruiting 0.01% Atropine studies.
Common questions
- Are there clinical trials studying 0.01% Atropine?
- Yes. Clin2 currently lists 8 recruiting studies that include 0.01% Atropine, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a 0.01% Atropine trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is 0.01% Atropine an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether 0.01% Atropine or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.